PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg, 30, 90 & 1000 count NDC # 33342-052-07, NDC #33342-052-10 & NDC # 33342-052-44, Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

Reported: July 6, 2022 Initiated: June 10, 2022 #D-1164-2022

Product Description

Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg, 30, 90 & 1000 count NDC # 33342-052-07, NDC #33342-052-10 & NDC # 33342-052-44, Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536

Reason for Recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
84/1000 count bottles
Distribution
Product was distributed nationwide.
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg, 30, 90 & 1000 count NDC # 33342-052-07, NDC #33342-052-10 & NDC # 33342-052-44, Rx Only, MFR: Macleods Pharma USA, Inc. Plainsboro, NJ 08536. Recalled by Macleods Pharma Usa Inc. Units affected: 84/1000 count bottles.
Why was this product recalled?
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Which agency issued this recall?
This recall was issued by the FDA Drug on July 6, 2022. Severity: Moderate. Recall number: D-1164-2022.